Related Experiment Video
Updated: Sep 16, 2025

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
Genomic and Functional Characterization of Novel Phages Targeting Multidrug-Resistant Acinetobacter baumannii
Alma Karen Orozco-Ochoa1, Beatriz Quiñones2, Jean Pierre González-Gómez1
1Laboratorio Nacional para la Investigación en Inocuidad Alimentaria (LANIIA), Centro de Investigación en Alimentación y Desarrollo, A.C. (CIAD), Carretera a Eldorado Km 5.5, Campo El Diez, Culiacán 80110, Sinaloa, Mexico.
Abstract:
Acinetobacter baumannii is an opportunistic pathogen and a major cause of nosocomial infections worldwide. This study aimed to isolate and characterize phages with lytic activity against multidrug-resistant A. baumannii strains to enable antibacterial alternatives. Eight phages (AKO8a, PS118, B612, MCR, IDQ7, 89P13, CRL20, and CIM23) were isolated and subjected to genomic, phylogenetic, and functional analyses. Antibacterial activity was assessed in vitro against A. baumannii strain AbAK04 by measuring optical density over 17 h at multiplicities of infection (MOIs) of 0.1, 1, and 10, using a repeated-measures design with time as a crossed factor and MOI as a nested factor. Tukey's post-hoc test identified significant bacterial growth reductions of 57-72% (p < 0.001). Specifically, phages PS118 and 89P13 reduced growth by 71% at MOI 10; CIM23, B612, and CRL20 achieved 68% reduction at MOI 1; and MCR reduced growth by 64% at MOIs 0.1 and 1. Notably, lytic phage MCR encodes a glycosyl hydrolase family 58 (GH58) enzyme, potentially contributing to its antibacterial activity. Genomic analyses confirmed absence of virulence and antibiotic resistance genes, with all phages classified as novel species within the Kagunavirus genus. These findings support the use of these phages as promising candidates for in vivo evaluation.
Insights
Eight novel phages show significant lytic activity against multidrug-resistant Acinetobacter baumannii, offering potential as antibacterial alternatives. These phages, classified as new Kagunavirus species, lack virulence genes and are safe for further development.
Area of Science:
- Microbiology
- Virology
- Genomics
Background:
- Acinetobacter baumannii is a significant opportunistic pathogen causing worldwide nosocomial infections.
- Multidrug resistance in A. baumannii necessitates the development of novel therapeutic strategies.
Purpose of the Study:
- To isolate and characterize bacteriophages with lytic activity against multidrug-resistant A. baumannii.
- To evaluate the potential of these phages as antibacterial alternatives.
Main Methods:
- Isolation and characterization of eight bacteriophages (AKO8a, PS118, B612, MCR, IDQ7, 89P13, CRL20, and CIM23).
- Genomic, phylogenetic, and functional analyses of isolated phages.
- In vitro assessment of antibacterial activity against A. baumannii using optical density measurements at various multiplicities of infection (MOIs).
Main Results:
- Significant bacterial growth reductions ranging from 57-72% (p < 0.001) were observed.
- Phages PS118 and 89P13 demonstrated 71% growth reduction at MOI 10.
- Phage MCR encodes a glycosyl hydrolase family 58 (GH58) enzyme; genomic analysis confirmed the absence of virulence and antibiotic resistance genes in all isolated phages.
- All phages were classified as novel species within the Kagunavirus genus.
Conclusions:
- The isolated phages exhibit potent lytic activity against multidrug-resistant A. baumannii.
- These novel Kagunavirus species are promising candidates for further in vivo evaluation as antibacterial agents.
- The absence of virulence and antibiotic resistance genes supports their safety profile.
Related Concept Videos
DNA Bacteriophages
Gene Regulation in Microbial Communities: Quorum Sensing
Lytic Cycle of Bacteriophages

